600422 昆药集团
已收盘 08-10 15:00:00
资讯
新帖
简况
港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售
智通财经 · 07-28
港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售
每周股票复盘：昆药集团（600422）拟减持不超244.3万股东京维立志博
证券之星 · 07-26
每周股票复盘：昆药集团（600422）拟减持不超244.3万股东京维立志博
昆药集团（600422）披露关于所持金融资产处置的公告，7月24日股价下跌3.85%
证券之星 · 07-24
昆药集团（600422）披露关于所持金融资产处置的公告，7月24日股价下跌3.85%
7月24日增减持汇总：ST宁科等8家公司披露增持情况，昆药集团、统一股份披露减持情况（表）
新浪证券 · 07-24
7月24日增减持汇总：ST宁科等8家公司披露增持情况，昆药集团、统一股份披露减持情况（表）
昆药集团：拟减持不超244.3022万股维立志博股票
每日经济新闻 · 07-24
昆药集团：拟减持不超244.3022万股维立志博股票
昆药集团（600422）披露2025年年度权益分派实施公告，7月21日股价下跌4.04%
证券之星 · 07-21
昆药集团（600422）披露2025年年度权益分派实施公告，7月21日股价下跌4.04%
每周股票复盘：昆药集团（600422）半年预亏4亿至3.3亿
证券之星 · 07-19
每周股票复盘：昆药集团（600422）半年预亏4亿至3.3亿
股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元
证券之星 · 07-15
股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元
昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%
证券之星 · 07-14
昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%
每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录
证券之星 · 07-12
每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录
昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%
证券之星 · 07-10
昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%
每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新
证券之星 · 07-05
每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新
昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%
证券之星 · 06-29
昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%
每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具
证券之星 · 06-28
每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具
昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%
证券之星 · 06-22
昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%
昆药集团：公司多渠道布局品牌传播
证券日报 · 06-16
昆药集团：公司多渠道布局品牌传播
股市必读：昆药集团（600422）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：昆药集团（600422）6月1日董秘有最新回复
昆药集团涨6.05%，东吴证券二个月前给出“买入”评级
证券之星 · 06-01
昆药集团涨6.05%，东吴证券二个月前给出“买入”评级
昆药集团：当前公司正抓紧排产以满足市场需求
证券之星 · 06-01
昆药集团：当前公司正抓紧排产以满足市场需求
5月14日昆药集团发布公告，股东增持730.38万股
证券之星 · 05-14
5月14日昆药集团发布公告，股东增持730.38万股
加载更多
公司概况
公司名称：
昆药集团股份有限公司
所属行业：
医药制造业
上市日期：
2000-12-06
主营业务：
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。
发行价格：
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":8.81,"timestamp":1786345201000,"preClose":8.82,"halted":0,"volume":10977556,"delay":0,"changeRate":-0.0011,"floatShares":757000000,"shares":757000000,"eps":0.1555,"marketStatus":"已收盘","change":-0.01,"latestTime":"08-10 15:00:00","open":8.83,"high":9.02,"low":8.8,"amount":97642400,"amplitude":0.0249,"askPrice":8.82,"askSize":58,"bidPrice":8.81,"bidSize":559,"shortable":0,"etf":0,"ttmEps":0.1555,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786411800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.82,"symbolType":"stock","openAndCloseTimeList":[[1786325400000,1786332600000],[1786338000000,1786345200000]],"highLimit":9.7,"lowLimit":7.94,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.28,"roa":"--","peRate":56.655949,"roe":"--","epsLYR":0.46,"committee":0.339511,"marketValue":6669000000,"turnoverRate":0.0145,"status":1,"floatMarketCap":6669000000},"requestUrl":"/m/hq/s/600422","defaultTab":"news","newsList":[{"id":"2654607680","title":"港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售","url":"https://stock-news.laohu8.com/highlight/detail?id=2654607680","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654607680?lang=zh_cn&edition=full","pubTime":"2026-07-28 14:14","pubTimestamp":1785219275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维立志博-B(09887)再跌超7%，截至发稿，跌6.89%，报54.05港元，成交额6.08亿港元。消息面上，7月24日，昆药集团公布，拟减持不超过244.3022万股维立志博股票。预计交易金额约1.32亿元。值得注意的是，本次减持刚好为维立志博解禁前夕。同时，维立志博联合创始人康小强博士表示，自愿延长其直接持有全部约787.5万股H股的禁售期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4588","600422","KCAI","HK0000500386.USD","BK0188","HK0000252152.HKD","BK0239","BK0028","BK0060","09887","BK4585","BK1161","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057251","title":"每周股票复盘：昆药集团（600422）拟减持不超244.3万股东京维立志博","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057251?lang=zh_cn&edition=full","pubTime":"2026-07-26 03:02","pubTimestamp":1785006138,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，昆药集团报收于8.73元，较上周的8.95元下跌2.46%。本周，昆药集团7月20日盘中最高价报9.19元。本周关注点公司公告汇总：昆药集团拟通过集中竞价或大宗交易减持不超过244.3022万股南京维立志博股份。昆药集团为进一步强化主业、优化资产结构，拟通过集中竞价、大宗交易等方式择机减持不超过244.3022万股南京维立志博生物科技股份有限公司股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09887","BK0060","BK0239","BK0188","BK0028","BK1161","HK0000252152.HKD","HK0000252160.HKD","600422","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033917","title":"昆药集团（600422）披露关于所持金融资产处置的公告，7月24日股价下跌3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653033917?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:45","pubTimestamp":1784904317,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，昆药集团报收于8.73元，较前一交易日下跌3.85%，最新总市值为66.08亿元。该股当日开盘9.01元，最高9.12元，最低8.7元，成交额达8946.66万元，换手率为1.33%。近日，昆药集团发布《关于所持金融资产处置的公告》。本次减持已获公司第十一届二十一次董事会审议通过，不构成关联交易和重大资产重组。交易实施期限为禁售期满后12个月内，最终交易作价和实施时间存在不确定性，目前无法确切预计对公司业绩的具体影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653508013","title":"7月24日增减持汇总：ST宁科等8家公司披露增持情况，昆药集团、统一股份披露减持情况（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2653508013","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653508013?lang=zh_cn&edition=full","pubTime":"2026-07-24 21:45","pubTimestamp":1784900700,"startTime":"0","endTime":"0","summary":"据不完全统计，7月24日盘后，包括ST宁科、青岛啤酒、温氏股份、中国宝安、北汽蓝谷、渤海汽车、泰禾智能、福田汽车在内的8家A股上市公司披露增持情况；昆药集团、统一股份披露减持情况。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：孙同怀","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-24/doc-iniixnfz4835270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0042","BK0070","BK0004","BK0174","BK0060","BK0081","BK0028","BK0188","BK0239","600165","BK0177","BK0227","BK0135","BK0229","600506","BK0102","BK0275","600422","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653108307","title":"昆药集团：拟减持不超244.3022万股维立志博股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2653108307","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653108307?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:48","pubTimestamp":1784886520,"startTime":"0","endTime":"0","summary":"【昆药集团：拟减持不超244.3022万股维立志博股票】7月24日，昆药集团公告称，为进一步强化主业、优化资产结构，公司拟通过集中竞价、大宗交易等方式择机减持不超过244.3022万股维立志博股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607243820568626.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607243820568626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09887","BK0060","HK0000252160.HKD","BK0188","600422","BK1161","BK0239","HK0000500386.USD","BK0028","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653991205","title":"昆药集团（600422）披露2025年年度权益分派实施公告，7月21日股价下跌4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653991205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653991205?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:22","pubTimestamp":1784643759,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，昆药集团报收于8.78元，较前一交易日下跌4.04%，最新总市值为66.46亿元。该股当日开盘9.14元，最高9.18元，最低8.78元，成交额达1.45亿元，换手率为2.14%。近日，昆药集团发布2025年年度权益分派实施公告：每股派发现金红利0.18元（含税），股权登记日为2026年7月29日，除权（息）日为2026年7月30日，现金红利发放日为2026年7月30日。本次利润分配以公司总股本756,975,757股为基数，共派发现金红利136,255,636.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230892","title":"每周股票复盘：昆药集团（600422）半年预亏4亿至3.3亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230892","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230892?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:13","pubTimestamp":1784398389,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，昆药集团报收于8.95元，较上周的8.28元上涨8.09%。本周，昆药集团7月16日盘中最高价报9.3元。本周关注点来自业绩披露要点：昆药集团预计2026年上半年归属净利润亏损3.3亿元至4亿元。公司公告汇总昆药集团股份有限公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元，扣除非经常性损益后的净利润为-43,000万元到-35,000万元，较上年同期由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651548365","title":"股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651548365?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:50","pubTimestamp":1784051419,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，昆药集团报收于8.91元，上涨1.48%，换手率2.98%，成交量22.54万手，成交额2.01亿元。业绩披露要点：昆药集团预计2026年1-6月归属净利润亏损3.3亿元至4亿元，扣非后净利润亏损3.5亿元至4.3亿元。公司公告汇总昆药集团2026年半年度业绩预告昆药集团股份有限公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元，扣除非经常性损益后的净利润为-43,000万元到-35,000万元，较上年同期出现大幅下滑并由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810412","title":"昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651810412?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:26","pubTimestamp":1784039176,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，昆药集团报收于8.91元，较前一交易日上涨1.48%，最新总市值为67.45亿元。该股当日开盘8.73元，最高9.08元，最低8.52元，成交额达2.01亿元，换手率为2.98%。近日，昆药集团股份有限公司披露2026年半年度业绩预告。公告显示，公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元，扣除非经常性损益后的净利润为-43,000万元到-35,000万元，较上年同期出现大幅下滑并由盈转亏。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","600422","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892152","title":"每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892152","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650892152?lang=zh_cn&edition=full","pubTime":"2026-07-12 03:22","pubTimestamp":1783797730,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，昆药集团报收于8.28元，较上周的8.27元上涨0.12%。本周，昆药集团7月6日盘中最高价报8.63元。7月10日盘中最低价报7.96元。昆药集团当前最新总市值62.68亿元，在中药板块市值排名32/66，在两市A股市值排名2655/5202。公司共57个产品进入该目录，新增3个产品。血塞通系列为核心中成药，2025年相关产品销售收入约90,242.25万元，占公司营业收入的13.72%。此次纳入将提升产品在基层医疗市场的可及性，支持慢病管理和银发健康战略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0188","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650136978","title":"昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650136978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650136978?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:48","pubTimestamp":1783694896,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，昆药集团报收于8.28元，较前一交易日上涨1.84%，最新总市值为62.68亿元。近日，昆药集团发布关于公司产品新纳入《国家基本药物目录》的公告。根据国家卫生健康委员会等部门发布的通知，昆药集团股份有限公司的络泰血塞通软胶囊、控股子公司昆明华润圣火药业有限公司的理洫王血塞通软胶囊、昆药集团血塞通药业股份有限公司的络泰血塞通滴丸新纳入《国家基本药物目录》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000045023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694203","title":"每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694203","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649694203?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:57","pubTimestamp":1783191428,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，昆药集团报收于8.27元，较上周的7.7元上涨7.4%。本周，昆药集团7月2日盘中最高价报8.53元。来自公司公告汇总：昆药集团通过2026年董事及高管薪酬方案，绩效年薪占比不低于60%。公司公告汇总昆药集团董事会于2026年6月29日收到刘军锋先生的书面辞职报告，其因个人原因申请辞去公司高级副总裁职务，辞任后不再担任公司任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600422","BK0188","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647308861","title":"昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647308861","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647308861?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:40","pubTimestamp":1782744026,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，昆药集团报收于8.05元，较前一交易日上涨4.55%，最新总市值为60.94亿元。该股当日开盘7.66元，最高8.14元，最低7.45元，成交额达8338.21万元，换手率为1.4%。近日，昆药集团发布《关于高级管理人员变更的公告》。公告显示，公司董事会于2026年6月29日收到刘军锋先生的书面辞职报告，因其个人原因申请辞去公司高级副总裁职务，辞任后不再担任公司任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0060","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646431531","title":"每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2646431531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646431531?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:13","pubTimestamp":1782587589,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，昆药集团报收于7.7元，较上周的8.09元下跌4.82%。本周，昆药集团6月23日盘中最高价报8.34元。6月26日盘中最低价报7.7元，股价触及近一年最低点。昆药集团当前最新总市值58.29亿元，在中药板块市值排名32/66，在两市A股市值排名2814/5206。会议听取了三位独立董事的述职报告。董事会总结了2025年在战略发展、公司治理、风险防控等方面的工作，并提出了2026年工作计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600422","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645732620","title":"昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645732620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645732620?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:37","pubTimestamp":1782139036,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，昆药集团报收于8.03元，较前一交易日下跌0.74%，最新总市值为60.79亿元。该股当日开盘8.07元，最高8.07元，最低7.76元，成交额达6630.81万元，换手率为1.11%。近日，昆药集团披露《2025年年度股东会会议资料》。公告显示，公司召开2025年年度股东会，审议并通过了2025年度董事会工作报告、利润分配方案、相关人员年度报酬、薪酬管理制度、2026年度董事及高管薪酬方案、拟注册发行不超过10亿元债务融资工具等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600422","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643750783","title":"昆药集团：公司多渠道布局品牌传播","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750783","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643750783?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:42","pubTimestamp":1781613720,"startTime":"0","endTime":"0","summary":"证券日报网讯 6月16日，昆药集团在互动平台回答投资者提问时表示，关于品牌宣传投放，公司多渠道布局品牌传播，央媒、地方权威媒体、健康科普平台、线下终端等均有分层投放布局；今年一季度，公司依托昆中药“脾胃大师”IP，携手《味道大师》美食纪录片登陆央视财经频道开展品牌露出。此外，在宣传形式方面，包含品牌形象推广、科普栏目、健康公开课等多元形式，相关投放根据年度品牌规划、销售周期动态调配。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-16/doc-inicrivp4306737.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-16/doc-inicrivp4306737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","BK0188","BK0028","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969514","title":"股市必读：昆药集团（600422）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969514","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640969514?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:22","pubTimestamp":1780338134,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，昆药集团报收于9.47元，上涨6.05%，换手率3.14%，成交量23.75万手，成交额2.2亿元。董秘最新回复投资者： 公司官方店的昆药生物肽牙膏卖缺货了，公司负责这个的领导是个吃白饭的请抓紧补货？后续公司将持续强化供应链统筹，保障产品的稳定供应。交易信息汇总资金流向6月1日主力资金净流入287.76万元，占总成交额1.31%；游资资金净流出3030.62万元，占总成交额13.79%；散户资金净流入2742.86万元，占总成交额12.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0060","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640328149","title":"昆药集团涨6.05%，东吴证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2640328149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640328149?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:34","pubTimestamp":1780302855,"startTime":"0","endTime":"0","summary":"今日昆药集团（600422）涨6.05%，收盘报9.47元。2026年3月24日，东吴证券研究员朱国广,向潇发布了对昆药集团的研报《2025年报点评：短期业绩承压，银发经济长期发展向好》，该研报对昆药集团给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为44.45%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为华泰证券的高初蕾。昆药集团（600422）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640939792","title":"昆药集团：当前公司正抓紧排产以满足市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2640939792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640939792?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:33","pubTimestamp":1780299203,"startTime":"0","endTime":"0","summary":"证券之星消息，昆药集团(600422)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：公司官方店的昆药生物肽牙膏卖缺货了，公司负责这个的领导是个吃白饭的请抓紧补货？昆药集团回复：尊敬的投资者，您好。当前公司正抓紧排产以满足市场需求，敬请关注官方渠道到货动态。后续公司将持续强化供应链统筹，保障产品的稳定供应。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100017148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0060","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712116","title":"5月14日昆药集团发布公告，股东增持730.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712116","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635712116?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:01","pubTimestamp":1778760067,"startTime":"0","endTime":"0","summary":"证券之星消息，5月14日昆药集团发布公告《昆药集团:昆药集团关于控股股东权益变动触及1%刻度的提示性公告》，其股东华润三九医药股份有限公司于2026年4月27日至2026年5月14日间合计增持730.38万股，占公司目前总股本的0.9649%，变动期间该股股价下跌18.52%，截止5月14日收盘报8.93元。股东增减持详情见下表：根据昆药集团2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400038414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786351675650,"stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":0.0851},{"period":"3month","weight":-0.0481},{"period":"6month","weight":-0.2821},{"period":"1year","weight":-0.3809},{"period":"ytd","weight":-0.2838}],"compareEarnings":[{"period":"1week","weight":0.0281},{"period":"1month","weight":-0.0078},{"period":"3month","weight":-0.0574},{"period":"6month","weight":-0.0309},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0073}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"55570人(较上一季度增加0.29%)","perCapita":"13622股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}